Epigral

{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,061.50",
    "chg": 9.2,
    "chgp": "0.87%",
    "dir": 1,
    "prev_price": "1,052.30",
    "mcapval": "4,579.45 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE071N01016",
    "curr_date": "Jul 16, 01:55 PM",
    "curr_time": "14:17 PM",
    "last_traded_at": "Jul 16, 01:55 PM IST",
    "bse_nse_vol": "27.6 k",
    "exc_status": "Active",
    "traded_date": "Jul 16, 2026",
    "traded_date_str": "2026 07 16",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd Surges 10.82% to Day's High of Rs 1082 — Outperforms Sector by 10.83 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-hits-intraday-high-with-1082-surge-on-13-jul-2026-4098198",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EpigralLtd_priceRelatedfactors_4098198.png",
        "date": "2026-07-13 10:01:35",
        "description": "The Sensex declined by 0.38% on 13 Jul 2026, while Epigral Ltd surged 10.82% to an intraday high of Rs 1082. This 10.83-percentage-point outperformance over its Specialty Chemicals sector peers highlights a distinctly stock-specific rally rather than a market-wide uplift."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4090460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EpigralLtd_mojoScore_4090460.png",
        "date": "2026-07-06 10:11:28",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-bearish-sentiment-4086996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EpigralLtd_technicaldot_4086996.png",
        "date": "2026-07-03 08:05:38",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a deteriorating market sentiment. Recent technical indicators reveal a transition from mildly bearish to outright bearish trends, with key momentum oscillators and moving averages signalling caution for investors amid a sustained price decline."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4072996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EpigralLtd_mojoScore_4072996.png",
        "date": "2026-06-25 10:11:07",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4052734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EpigralLtd_mojoScore_4052734.png",
        "date": "2026-06-14 10:10:29",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4033427",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EpigralLtd_mojoScore_4033427.png",
        "date": "2026-06-03 10:11:38",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4007829",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_mojoScore_4007829.png",
        "date": "2026-05-23 10:10:32",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4007812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_mojoScore_4007812.png",
        "date": "2026-05-23 10:10:32",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 May 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-specialty-chemicals-sector-4004265",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_valuationdot_4004265.png",
        "date": "2026-05-22 08:01:17",
        "description": "Epigral Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, despite ongoing challenges in the specialty chemicals sector. This recalibration reflects a more balanced price-to-earnings (P/E) and price-to-book value (P/BV) ratio relative to its historical averages and peer group, signalling a potential inflection point for investors assessing the stock’s price attractiveness."
      }
    ],
    "total": 624,
    "sid": "1003523",
    "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>50%</strong> dividend, ex-date: 01 Jun 26",
          "dt": "2026-06-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Epigral Ltd Surges 10.82% to Day's High of Rs 1082 — Outperforms Sector by 10.83 Percentage Points

2026-07-13 10:01:35

The Sensex declined by 0.38% on 13 Jul 2026, while Epigral Ltd surged 10.82% to an intraday high of Rs 1082. This 10.83-percentage-point outperformance over its Specialty Chemicals sector peers highlights a distinctly stock-specific rally rather than a market-wide uplift.

Read full news article

Epigral Ltd is Rated Sell

2026-07-06 10:11:28

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment

2026-07-03 08:05:38

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a deteriorating market sentiment. Recent technical indicators reveal a transition from mildly bearish to outright bearish trends, with key momentum oscillators and moving averages signalling caution for investors amid a sustained price decline.

Read full news article

Epigral Ltd is Rated Sell

2026-06-25 10:11:07

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Epigral Ltd is Rated Sell

2026-06-14 10:10:29

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Epigral Ltd is Rated Sell

2026-06-03 10:11:38

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Epigral Ltd is Rated Sell

2026-05-23 10:10:32

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Epigral Ltd is Rated Sell

2026-05-23 10:10:32

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 May 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector

2026-05-22 08:01:17

Epigral Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, despite ongoing challenges in the specialty chemicals sector. This recalibration reflects a more balanced price-to-earnings (P/E) and price-to-book value (P/BV) ratio relative to its historical averages and peer group, signalling a potential inflection point for investors assessing the stock’s price attractiveness.

Read full news article

View All News